Background: Cardiovascular diseases are emerging as a major cause of mortality and disability in India. Coronary artery Calcium (CAC) has been proposed as an additional tool for risk re-stratification for Primary prevention. However, there is a lack of data for its incremental value assessment in Indian patients. Methods: This study included 150 patients presenting with risk factors for Cardiovascular Diseases or Symptoms. 10-year risk of CVD was calculated using two risk assessment models Revised American College of Cardiology/American Heart Association (Risk ACC/AHA) and WHO Risk Prediction Charts. CT Angiography and Coronary Artery Calcium Scoring was done in each patient. Results: 48.2 % (28/57) of patients in Statins recommended category (10 yr ASCVD Risk >7.5 %) and 11/17 (64.7%) in Statin Considered group (ASCVD Risk 5-7.5 %) according to guidelines had CAC Zero. 13/75 (17.3 %) of patients in whom statin was not recommended had a non-zero Coronary artery Calcium. A total of 52/150 (34.6%) (Statin not needed
Introduction
Cardiovascular risk assessment is the keystone of primary prevention of atherosclerotic CV disease (ASCVD) [1, 2] . Future risk assessment is typically calculated in 10 year or lifetime basis and helps in tailoring the therapy. Population based risk calculators like pooled cohort risk equation, WHO-ISH Risk score and Framingham Risk Score have been typically used for these calculations. Newer tools like CACS (coronary artery calcium Score), CIMT (Carotid Intima Media thickness) and hsCRP have been proposed for adjuvants for better risk stratification [3] [4] [5] .
CACS has been shown to be an excellent predictor of CV Risk events [6] [7] [8] [9] [10] [11] which considerably helps in risk restratification in these cohorts. Some studies have suggested using 'power of zero' [12] [13] [14] [15] [16] ; using Zero calcium Score to downgrade statin therapy in various primary prevention cohorts. In a recent meta-analysis the event rate in 29,312 individuals was very low (0.47 %) over a period of mean follow up of 50 years and these individuals had a relative risk of 0.15 in comparison to CACS > 0, thereby implying an 85% lower risk for individuals with zero calcium score [17] .
Recent AHA update for primary prevention [18] suggests that CACS be now used as a two-way tool for moving individuals both up and down the risk spectrum) for individuals in whom treatment might be considered. A recent study suggests up to half of patients in the intermediate risk group could be taken off statins (as they have CAC of zero) using this approach [17] .
However, we could find no Indian studies in literature evaluating the effect of this approach on primary prevention strategy.
Hence this study was undertaken to evaluate the incremental effect of CACS on Risk assessment strategies for primary prevention in our cohort. 
Material and Methods

Association of CAC with WHO ISH Risk Category
There was a Non-significant association between CAC category. andwho_risk. The chi-square statistic was 10.04 .
The degree of freedom was 6 and P value was 0.12. The distribution is described in 
Association between CAC Zero and Risk Factors
We can see in Figure 3 , Probability of CAC > Zero rises when number of Risk factors increase. Other studies also report reclassification in range of 30- 
Conclusion
Our study shows that almost one third of the population will be re-stratified regarding their lifetime use if CAC Scoring is used in addition to 10 yr ASCVD Score for use of statins as mode of primary prevention in Indian 
